These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10754522)

  • 1. Synthetic inhibitor of matrix metalloproteinases (batimastat) reduces prostate cancer growth in an orthotopic rat model.
    Lein M; Jung K; Le DK; Hasan T; Ortel B; Borchert D; Winkelmann B; Schnorr D; Loenings SA
    Prostate; 2000 May; 43(2):77-82. PubMed ID: 10754522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
    Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
    J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat model.
    Lein M; Jung K; Ortel B; Stephan C; Rothaug W; Juchem R; Johannsen M; Deger S; Schnorr D; Loening S; Krell HW
    Oncogene; 2002 Mar; 21(13):2089-96. PubMed ID: 11960381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
    Taraboletti G; Garofalo A; Belotti D; Drudis T; Borsotti P; Scanziani E; Brown PD; Giavazzi R
    J Natl Cancer Inst; 1995 Feb; 87(4):293-8. PubMed ID: 7535861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models.
    Watson SA; Morris TM; Robinson G; Crimmin MJ; Brown PD; Hardcastle JD
    Cancer Res; 1995 Aug; 55(16):3629-33. PubMed ID: 7627972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase inhibition prevents colon cancer peritoneal carcinomatosis development and prolongs survival in rats.
    Aparicio T; Kermorgant S; Dessirier V; Lewin MJ; Lehy T
    Carcinogenesis; 1999 Aug; 20(8):1445-51. PubMed ID: 10426790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of matrix metalloproteinase inhibitor batimastat on breast cancer regrowth and metastasis in athymic mice.
    Sledge GW; Qulali M; Goulet R; Bone EA; Fife R
    J Natl Cancer Inst; 1995 Oct; 87(20):1546-50. PubMed ID: 7563189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.
    Low JA; Johnson MD; Bone EA; Dickson RB
    Clin Cancer Res; 1996 Jul; 2(7):1207-14. PubMed ID: 9816289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.
    Giavazzi R; Garofalo A; Ferri C; Lucchini V; Bone EA; Chiari S; Brown PD; Nicoletti MI; Taraboletti G
    Clin Cancer Res; 1998 Apr; 4(4):985-92. PubMed ID: 9563894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The matrix metalloproteinase inhibitor batimastat inhibits the lung colonisation of orthotopically implanted malignant pancreatic tumor cells in SCID mice.
    Mirzaie M; Herse B; Oster O; Schöndube F
    Swiss Surg; 2002; 8(4):165-70. PubMed ID: 12227109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo.
    Della Porta P; Soeltl R; Krell HW; Collins K; O'Donoghue M; Schmitt M; Krüger A
    Anticancer Res; 1999; 19(5B):3809-16. PubMed ID: 10628317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the metastatic spread and growth of B16-BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor.
    Chirivi RG; Garofalo A; Crimmin MJ; Bawden LJ; Stoppacciaro A; Brown PD; Giavazzi R
    Int J Cancer; 1994 Aug; 58(3):460-4. PubMed ID: 8050828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat.
    Holst-Hansen C; Low JA; Stephens RW; Johnson MD; Carmeliet P; Frandsen TL; Brünner N; Dickson RB
    Breast Cancer Res Treat; 2001 Aug; 68(3):225-37. PubMed ID: 11727959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo.
    Zervos EE; Norman JG; Gower WR; Franz MG; Rosemurgy AS
    J Surg Res; 1997 May; 69(2):367-71. PubMed ID: 9224409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
    Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
    Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The matrix metalloproteinase inhibitor batimastat inhibits angiogenesis in liver metastases of B16F1 melanoma cells.
    Wylie S; MacDonald IC; Varghese HJ; Schmidt EE; Morris VL; Groom AC; Chambers AF
    Clin Exp Metastasis; 1999 Mar; 17(2):111-7. PubMed ID: 10411102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).
    Eccles SA; Box GM; Court WJ; Bone EA; Thomas W; Brown PD
    Cancer Res; 1996 Jun; 56(12):2815-22. PubMed ID: 8665519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model.
    Lokeshwar BL; Selzer MG; Zhu BQ; Block NL; Golub LM
    Int J Cancer; 2002 Mar; 98(2):297-309. PubMed ID: 11857423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of an orthotopic model of human lung cancer with regional and systemic metastases.
    Johnston MR; Mullen JB; Pagura ME; Howard RB
    Ann Thorac Surg; 2001 Apr; 71(4):1120-5. PubMed ID: 11308147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.